International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

K. M. Giacomini, P. V. Balimane, S. K. Cho, M. Eadon, T. Edeki, K. M. Hillgren, S-M Huang, Y. Sugiyama, D. Weitz, Y. Wen, C. Q. Xia, S. W. Yee, H. Zimdahl, Mikko Niemi, Int Transporter Consortium

Forskningsoutput: TidskriftsbidragArtikelVetenskaplig

Originalspråkengelska
TidskriftClinical Pharmacology and Therapeutics
Volym94
Utgåva1
Sidor (från-till)23-26
Antal sidor4
ISSN0009-9236
DOI
StatusPublicerad - jul 2013
MoE-publikationstypB1 Artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

  • 317 Farmaci

Citera det här

Giacomini, K. M., Balimane, P. V., Cho, S. K., Eadon, M., Edeki, T., Hillgren, K. M., ... Int Transporter Consortium (2013). International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. Clinical Pharmacology and Therapeutics, 94(1), 23-26. https://doi.org/10.1038/clpt.2013.12
Giacomini, K. M. ; Balimane, P. V. ; Cho, S. K. ; Eadon, M. ; Edeki, T. ; Hillgren, K. M. ; Huang, S-M ; Sugiyama, Y. ; Weitz, D. ; Wen, Y. ; Xia, C. Q. ; Yee, S. W. ; Zimdahl, H. ; Niemi, Mikko ; Int Transporter Consortium. / International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. I: Clinical Pharmacology and Therapeutics. 2013 ; Vol. 94, Nr. 1. s. 23-26.
@article{183ae19b5c4345eeaa3d06ad169f3e54,
title = "International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms",
keywords = "MARKEDLY AFFECTS, PHARMACOKINETICS, ROSUVASTATIN, VARIANTS, 317 Pharmacy",
author = "Giacomini, {K. M.} and Balimane, {P. V.} and Cho, {S. K.} and M. Eadon and T. Edeki and Hillgren, {K. M.} and S-M Huang and Y. Sugiyama and D. Weitz and Y. Wen and Xia, {C. Q.} and Yee, {S. W.} and H. Zimdahl and Mikko Niemi and {Int Transporter Consortium}",
year = "2013",
month = "7",
doi = "10.1038/clpt.2013.12",
language = "English",
volume = "94",
pages = "23--26",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "1",

}

Giacomini, KM, Balimane, PV, Cho, SK, Eadon, M, Edeki, T, Hillgren, KM, Huang, S-M, Sugiyama, Y, Weitz, D, Wen, Y, Xia, CQ, Yee, SW, Zimdahl, H, Niemi, M & Int Transporter Consortium 2013, 'International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms', Clinical Pharmacology and Therapeutics, vol. 94, nr. 1, s. 23-26. https://doi.org/10.1038/clpt.2013.12

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms. / Giacomini, K. M.; Balimane, P. V.; Cho, S. K.; Eadon, M.; Edeki, T.; Hillgren, K. M.; Huang, S-M; Sugiyama, Y.; Weitz, D.; Wen, Y.; Xia, C. Q.; Yee, S. W.; Zimdahl, H.; Niemi, Mikko; Int Transporter Consortium.

I: Clinical Pharmacology and Therapeutics, Vol. 94, Nr. 1, 07.2013, s. 23-26.

Forskningsoutput: TidskriftsbidragArtikelVetenskaplig

TY - JOUR

T1 - International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

AU - Giacomini, K. M.

AU - Balimane, P. V.

AU - Cho, S. K.

AU - Eadon, M.

AU - Edeki, T.

AU - Hillgren, K. M.

AU - Huang, S-M

AU - Sugiyama, Y.

AU - Weitz, D.

AU - Wen, Y.

AU - Xia, C. Q.

AU - Yee, S. W.

AU - Zimdahl, H.

AU - Niemi, Mikko

AU - Int Transporter Consortium

PY - 2013/7

Y1 - 2013/7

KW - MARKEDLY AFFECTS

KW - PHARMACOKINETICS

KW - ROSUVASTATIN

KW - VARIANTS

KW - 317 Pharmacy

U2 - 10.1038/clpt.2013.12

DO - 10.1038/clpt.2013.12

M3 - Article

VL - 94

SP - 23

EP - 26

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -